HF
RGNX icon

HRT Financial’s Regenxbio RGNX Stock Holding History

HRT Financial’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.94M Buy
351,489
+51,574
+17% +$542K 0.01% 1331
2025
Q4 		$4.32M Buy
299,915
+127,729
+74% +$1.59M 0.01% 850
2025
Q3 		$1.66M Buy
+172,186
New +$1.52M 0.01% 1253
2025
Q2 		– Sell
-183,424
Closed -$1.31M – 3392
2025
Q1 		$1.31M Sell
183,424
-179,979
-50% -$1.34M 0.01% 1003
2024
Q4 		$2.81M Buy
363,403
+129,404
+55% +$1.21M 0.01% 610
2024
Q3 		$2.45M Buy
+233,999
New +$2.85M 0.01% 801
2024
Q1 		– Sell
-15,828
Closed -$284K – 2963
2023
Q4 		$284K Buy
+15,828
New +$279K ﹤0.01% 1649
2023
Q3 		– Sell
-18,939
Closed -$378K – 2979
2023
Q2 		$378K Buy
+18,939
New +$365K ﹤0.01% 1491
2023
Q1 		– Sell
-44,462
Closed -$1.01M – 3081
2022
Q4 		$1.01M Buy
44,462
+36,711
+474% +$830K 0.01% 960
2022
Q3 		$204K Buy
+7,751
New +$230K ﹤0.01% 2202
2021
Q1 		– Sell
-6,895
Closed -$312K – 3075
2020
Q4 		$312K Sell
6,895
-25,514
-79% -$892K 0.01% 1267
2020
Q3 		$891K Buy
+32,409
New +$1.06M 0.03% 614
2020
Q1 		– Sell
-8,317
Closed -$340K – 1256
2019
Q4 		$340K Buy
+8,317
New +$329K 0.01% 693

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial's RGNX Position: Q1 2026 in Review

HRT Financial increased its Regenxbio (RGNX) stake by 17% in Q1 2026, buying an estimated $542K and bringing the position to 351,489 shares worth $2.94M. The position accounts for 0.01% of the portfolio, ranked #1331.

HRT Financial first reported a position in RGNX in Q4 2019 and has held it in 13 quarters since. The position peaked at $4.32M in Q4 2025. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.

  • HRT Financial held 351,489 shares of Regenxbio worth $2.94M as of Q1 2026.
  • HRT Financial bought 51,574 Regenxbio shares in Q1 2026, an estimated $542K.
  • Regenxbio made up 0.01% of HRT Financial's portfolio in Q1 2026, its #1331 holding.
  • HRT Financial first reported a position in Regenxbio in Q4 2019 and has held it in 13 quarters since.
  • HRT Financial's Regenxbio position peaked at $4.32M in Q4 2025.
  • 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.